Condition: Acute Respiratory Distress Syndrome · Infections · Sponsor: BioAegis Therapeutics Inc.
BTI-203 is a randomized, double-blind, placebo-controlled, multicenter, Phase 2 proof-of-concept (POC) study to evaluate the efficacy and safety of rhu-pGSN plus standard of care (SOC) in subjects with moderate-to-severe ARDS (P/F ratio ≤150) due to pneumonia or other infections. Potential subjects hospitalized with pneumonia or other infections are to be screened within 24 hours of diagnosis of ARDS.
This description comes directly from the study's public registry record.
Howard Levy, MD PhD · 848-992-5888 · hlevy@hlevyconsulting.com
Dmytro Pomishchyk · 502-648-2138 · dmytro.pomishchyk@ergomedgroup.com
Always discuss trial participation with your own doctor first.
| Cedars-Sinai Medical Center | Los Angeles, California, United States | Recruiting |
| Wellstar MCG Augusta University | Augusta, Georgia, United States | Recruiting |
| Northwestern University - Pulmonary and Critical Care Medicine | Chicago, Illinois, United States | Recruiting |
| University of Louisville Hospital - Jewish Hospital | Louisville, Kentucky, United States | Recruiting |
| University of Louisville-Jewish Hospital | Louisville, Kentucky, United States | Recruiting |
| Mayo Clinic | Rochester, Minnesota, United States | Recruiting |
| Hannibal Regional Hospital | Hannibal, Missouri, United States | Recruiting |
| Bryan Medical Center | Lincoln, Nebraska, United States | Recruiting |
| New York University Grossman School of Medicine | New York, New York, United States | Not Yet Recruiting |
| Penn State Health - Milton S. Hershey Medical Center | Hershey, Pennsylvania, United States | Recruiting |
| Penn State Health - Milton S. Hershey Medical Center | Hershey, Pennsylvania, United States | Recruiting |
| University of Pittsburgh Medical Center | Pittsburgh, Pennsylvania, United States | Recruiting |
+ 58 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05947955